The Expression Pattern of Annexin A1 in Urinary Bladder Urothelial Carcinoma and Its Clinicopathologic Significance
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Annexin A1 (ANXA1) is known to be involved in the progression and differentiation of various tumors. However, its significance and role in bladder carcinogenesis has not been fully elucidated. To determine the role ANXA1 plays in urothelial carcinoma (UC), we investigated the expression of ANXA1 protein in normal urothelial tissue, carcinoma in situ (CIS), and UC of the urinary bladder. Methods: Protein expression level of ANXA1 and its subcellular localization were analyzed in 88 cases of UCs and corresponding 24 normal tissues and 24 CISs by immunohistochemistry. Results: ANXA1 was significantly down-regulated at all subcellular localization in CIS and in the cytoplasm and membrane of cells of UC, compared to normal tissues. No significant correlation between ANXA1 expression level and tumor depth (pT), growth pattern, and recurrence was found. However, cytoplasmic and membranous ANXA1 were significantly up-regulated in high grade than in low grade UC (p=0.02 in cytoplasm and p=0.03 in membrane). Conclusions: These results suggest that ANXA1 dysregulation is involved in urothelial carcinogenesis and ANXA1 is potentially a marker for the pathologic differentiation of UC.
Abstract
Background: Annexin A1 (ANXA1) is known to be involved in the progression and differentiation of various tumors. However, its significance and role in bladder carcinogenesis has not been fully elucidated. To determine the role ANXA1 plays in urothelial carcinoma (UC), we investigated the expression of ANXA1 protein in normal urothelial tissue, carcinoma in situ (CIS), and UC of the urinary bladder. Methods: Protein expression level of ANXA1 and its subcellular localization were analyzed in 88 cases of UCs and corresponding 24 normal tissues and 24 CISs by immunohistochemistry. Results: ANXA1 was significantly down-regulated at all subcellular localization in CIS and in the cytoplasm and membrane of cells of UC, compared to normal tissues. No significant correlation between ANXA1 expression level and tumor depth (pT), growth pattern, and recurrence was found. However, cytoplasmic and membranous ANXA1 were significantly up-regulated in high grade than in low grade UC (p=0.02 in cytoplasm and p=0.03 in membrane). Conclusions: These results suggest that ANXA1 dysregulation is involved in urothelial carcinogenesis and ANXA1 is potentially a marker for the pathologic differentiation of UC.
참고문헌 (28)
- Ernst JD, "Annexins possess functionally distinguishable Ca2+ and phospholipid binding domains", Biochem Biophys Res Commun, 200, pp.867~876 (1994)
- Raynal P, "Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid- binding proteins", Biochim Biophys Acta, 1197, pp.63~93 (1994)
- Northup JK, "Evaluation of the antiinflammatory and phospholipase- inhibitory activity of calpactin II", lipocortin I, 1988, pp.82, 1347~1352
- Errasfa M, "Inhibition of phospholipase A2 activity of guinea-pig alveolar macrophages by lipocortin-like proteins purified from mice lung", Biochem Biophys Res Commun, 153, pp.1267~1270 (1988)
- Croxtall J, "The role of lipocortin 1 in the regulation of A549 cell proliferation and leukocyte migration", J Lipid Mediat, 6, pp.295~302 (1993)
- Sakamoto T, "Modulation of cell death pathways to apoptosis and necrosis of H2O2-treated rat thymocytes by lipocortin I", Biochem Biophys Res Commun, 220, pp.643~647 (1996)
- Frey BM, "Annexin I modulates cell functions by controlling intracellular calcium release", FASEB J, 13, pp.2235~2245 (1999)
- Hsiang CH, "The impact of altered annexin I protein levels on apoptosis and signal transduction pathways in prostate cancer cells", Prostate, 66, pp.1413~1424 (2006)
- Masaki T, "Enhanced expression of the protein kinase substrate annexin in human hepatocellular carcinoma", Hepatology, 24, pp.72~81 (1996)
- Bai XF, "Overexpression of annexin 1 in pancreatic cancer and its clinical significance", World J Gastroenterol, 10, pp.1466~1470 (2004)
- Falini B, "Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANX A1)", Lancet, 363, pp.1869~1870 (2004)
- Paweletz CP, "Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma", Cancer Res, 60, pp.6293~6297 (2000)
- Kang JS, "Dysregulation of annexin I protein expression in high-grade prostatic intraepithelial neoplasia and prostate cancer", Clin Cancer Res, 8, pp.117~123 (2002)
- Vishwanatha JK, "Absence of annexin I expression in B-cell non-Hodgkin’s lymphomas and cell lines", BMC Cancer, 4, pp.8~ (2004)
- Silistino-Souza R, "Annexin 1: differential expression in tumor and mast cells in human larynx cancer", Int J Cancer, 120, pp.2582~2589 (2007)
- Mohiti J, "The nuclear location of annexin V in the human osteosarcoma cell line MG-63 depends on serum factors and tyrosine kinase signaling pathways", Exp Cell Res, 234, pp.98~104 (1997)
- Radke S, "Specific association of annexin 1 with plasma membrane-resident and internalized EGF receptors mediated through the protein core domain", FEBS Lett, 578, pp.95~98 (2004)
- Lin CY, "Nuclear localization of annexin A1 is a prognostic factor in oral squamous cell carcinoma", J Surg Oncol, 97, pp.544~550 (2008)
- Nomura H, "Down-regulation of plasma membranous annexin A1 protein expression in premalignant and malignant lesions of the oral cavity: correlation with epithelial differentiation", J Cancer Res Clin Oncol, 135, pp.943~949 (2009)
- Jemal A, "Cancer statistics, 2007", CA Cancer J Clin, 57, pp.43~66 (2007)
- Baris D, "A case-control study of smoking and bladder cancer risk: emergent patterns over time", J Natl Cancer Inst, 101, pp.1553~1561 (2009)
- Wu XR, "Urothelial tumorigenesis: a tale of divergent pathways", Nat Rev Cancer, 5, pp.713~725 (2005)
- Cui L, "Overexpression of annexin a1 induced by terephthalic acid calculi in rat bladder cancer", Proteomics, 7, pp.4192~4202 (2007)
- Li CF, "Annexin- I overexpression is associated with tumour progression and independently predicts inferior disease-specific and metastasis-free survival in urinary bladder urothelial carcinoma", Pathology, 42, pp.43~49 (2010)
- Dreier R, "Differential expression of annexins I, II and IV in human tissues: an immunohistochemical study", Histochem Cell Biol, 110, pp.137~148 (1998)
- Alves VA, "Annexin A1 subcellular expression in laryngeal squamous cell carcinoma", Histopathology, 53, pp.715~727 (2008)
- Lim LH, "Annexin 1: the new face of an old molecule", FASEB J, 21, pp.968~975 (2007)
- Wang KL, "Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome", Clin Cancer Res, 12, pp.4598~4604 (2006)